Javascript must be enabled to continue!
Adverse Events Following Immunization (AEFI) with CoronaVac COVID-19 Vaccine among Clinical Clerkship Students at the Faculty of Medicine, Syarif Hidayatullah State Islamic University, Jakarta, Indonesia
View through CrossRef
Objective: Clinical clerkship students, as adolescent health workers, have been first recipients of the COVID-19 vaccination programme. The success rate and trust of recipients in the program have been impacted by adverse events following immunization (AEFI). This study aims to determine the AEFI of the CoronaVac vaccine among clinical clerkship students at the Faculty of Medicine, State Islamic University, Jakarta.
Material and Methods: This study used cross sectional methods with a total of 225 subjects completing a questionnaire. The CoronaVac vaccine was administered twice with 2 week interval. AEFI was evaluated after 30 minutes, 24 hours, and on the third day.
Results and discussion: 73.3% of the participants were female, 20-25 years old. AEFIs were found in 57.8 % of all participants in the first and second doses vaccination. The most common local AEFI was pain at the site injection, accounting 27.1 % which occurred 30 minutes after second dose vaccination. The most common systemic AEFI was drowsiness, accounting for 18 % which occurred 24 hours after first dose vaccination. Other systemic AEFIs were headache, fatigue, and chills. There was significant association between AEFIs and females but no significant association with history of allergy, comorbidities, and history of previous COVID-19 . AEFIs were mild, no special treatment or hospitalization were required.
Conclusion: The AEFIs of the CoronaVac vaccine among students were mild and had significant association with females. The study is expected to increase the public’s confidence in the COVID-19 vaccination program and to create awareness of its safety.
Bangladesh Journal of Medical Science Vol. 22 No. 03 July’23 Page :545-552
Bangladesh Academy of Sciences
Title: Adverse Events Following Immunization (AEFI) with CoronaVac COVID-19 Vaccine among Clinical Clerkship Students at the Faculty of Medicine, Syarif Hidayatullah State Islamic University, Jakarta, Indonesia
Description:
Objective: Clinical clerkship students, as adolescent health workers, have been first recipients of the COVID-19 vaccination programme.
The success rate and trust of recipients in the program have been impacted by adverse events following immunization (AEFI).
This study aims to determine the AEFI of the CoronaVac vaccine among clinical clerkship students at the Faculty of Medicine, State Islamic University, Jakarta.
Material and Methods: This study used cross sectional methods with a total of 225 subjects completing a questionnaire.
The CoronaVac vaccine was administered twice with 2 week interval.
AEFI was evaluated after 30 minutes, 24 hours, and on the third day.
Results and discussion: 73.
3% of the participants were female, 20-25 years old.
AEFIs were found in 57.
8 % of all participants in the first and second doses vaccination.
The most common local AEFI was pain at the site injection, accounting 27.
1 % which occurred 30 minutes after second dose vaccination.
The most common systemic AEFI was drowsiness, accounting for 18 % which occurred 24 hours after first dose vaccination.
Other systemic AEFIs were headache, fatigue, and chills.
There was significant association between AEFIs and females but no significant association with history of allergy, comorbidities, and history of previous COVID-19 .
AEFIs were mild, no special treatment or hospitalization were required.
Conclusion: The AEFIs of the CoronaVac vaccine among students were mild and had significant association with females.
The study is expected to increase the public’s confidence in the COVID-19 vaccination program and to create awareness of its safety.
Bangladesh Journal of Medical Science Vol.
22 No.
03 July’23 Page :545-552.
Related Results
Surveillance System Evaluation for COVID-19 Vaccine–Associated Adverse Events Following Immunization (AEFI), Sindh Pakistan (2021) (Preprint)
Surveillance System Evaluation for COVID-19 Vaccine–Associated Adverse Events Following Immunization (AEFI), Sindh Pakistan (2021) (Preprint)
BACKGROUND
In February 2021, a mass vaccination campaign commenced in Sindh Province in response to the COVID-19 epidemic. An adverse-events-following-immun...
Adverse Events Following Immunization (AEFI) Reporting in Urban and Rural Bangladesh
Adverse Events Following Immunization (AEFI) Reporting in Urban and Rural Bangladesh
Complete reporting and management of adverse events following immunization (AEFIs) helps maintain the quality of vaccine delivery and monitor vaccine safety. We assessed AEFI repor...
Frequency, Timing, Burden and Recurrence of Adverse Events Following Immunization After HPV Vaccine Based on a Cohort Event Monitoring Study in the Netherlands
Frequency, Timing, Burden and Recurrence of Adverse Events Following Immunization After HPV Vaccine Based on a Cohort Event Monitoring Study in the Netherlands
Background/Objectives: The aim of this study was to systematically assess Adverse Events Following Immunization (AEFI) among children following administration of the human papillom...
Heterologous prime-boost immunization with CoronaVac and Convidecia
Heterologous prime-boost immunization with CoronaVac and Convidecia
ABSTRACTBackgroundThe safety and immunogenicity of heterologous prime-boost COVID-19 vaccine regimens with one shot of a recombinant adenovirus type-5-vectored COVID-19 vaccine Con...
Adverse Events Following Immunization (AEFI) of COVID-19 Vaccine: A Descriptive Survey in Malang City
Adverse Events Following Immunization (AEFI) of COVID-19 Vaccine: A Descriptive Survey in Malang City
Vaccination is used to stop the transmission of COVID-19. However, it can stimulate Adverse Event Following Immunization (AEFI) symptoms, ranging from mild to severe. This study ai...
Myocarditis and Pericarditis following COVID-19 Vaccination in Thailand
Myocarditis and Pericarditis following COVID-19 Vaccination in Thailand
Background: Myocarditis and pericarditis cases following Coronavirus 2019 (COVID-19) vaccination were reported worldwide. In Thailand, COVID-19 vaccines were approved for emergency...
SARS-CoV-2 infection rates after different vaccination schemes
SARS-CoV-2 infection rates after different vaccination schemes
Objective:
To identify effects of various nationwide vaccination protocols on the evolution of new SARS-CoV-2 infections among adult population and to evaluate the safe...
Prevalence and pattern of adverse events following COVID 19 vaccination among adult population in Sokoto metropolis, northwest, Nigeria
Prevalence and pattern of adverse events following COVID 19 vaccination among adult population in Sokoto metropolis, northwest, Nigeria
Abstract
Background
COVID-19 still poses a major public health challenge worldwide and vaccination remains one of the major int...

